Literature DB >> 17195066

Late onset systemic lupus erythematosus: no substantial differences using different cut-off ages.

Melissa Padovan1, Marcello Govoni, Gabriella Castellino, Nicoletta Rizzo, Maria Fotinidi, Francesco Trotta.   

Abstract

To compare the clinical, laboratory and immunological features of a group of Caucasian systemic lupus erythematosus (SLE) patients in relation to age at disease onset. Three groups of patients with different ages at disease onset were analysed and compared: group A (30 patients, >or=65 years); group B (62 patients, 50-64 years) and group C (163 patients, <50 years). All patients were regularly followed-up for a mean period of 6.5 years. Female predominance was reduced in groups A and B. Time-lapse between disease onset and diagnosis was longer in group A and B. There were no statistically significant differences in clinical features. The only relevant difference was observed in peripheral nervous system (PNS) involvement, more frequent in group A. Anti-dsDNA and RF were more frequent in group A. Complement levels were reduced more frequently in group C. No differences were observed in disease activity scores, while SLICC/ACR score was higher in group A. In Caucasian SLE patients, age at disease onset is not associated with differences in clinical features apart from a more frequent PNS involvement in elderly patients. In the same group, the organ damage seems to develop more rapidly mostly due to higher susceptibility to jatrogenic side effects.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17195066     DOI: 10.1007/s00296-006-0284-3

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   3.580


  45 in total

Review 1.  Systemic lupus erythematosus in the elderly.

Authors:  G M Kammer; N Mishra
Journal:  Rheum Dis Clin North Am       Date:  2000-08       Impact factor: 2.670

2.  Clinical profile of patients with late-onset SLE: not a benign subgroup.

Authors:  S K Mak; E K Lam; A K Wong
Journal:  Lupus       Date:  1998       Impact factor: 2.911

3.  A meta-analysis of the clinical manifestations of older-onset systemic lupus erythematosus.

Authors:  M M Ward; R P Polisson
Journal:  Arthritis Rheum       Date:  1989-10

4.  Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1,000 patients. The European Working Party on Systemic Lupus Erythematosus.

Authors:  R Cervera; M A Khamashta; J Font; G D Sebastiani; A Gil; P Lavilla; I Doménech; A O Aydintug; A Jedryka-Góral; E de Ramón
Journal:  Medicine (Baltimore)       Date:  1993-03       Impact factor: 1.889

5.  Late onset systemic lupus erythematosus.

Authors:  S B Baker; J R Rovira; E W Campion; J A Mills
Journal:  Am J Med       Date:  1979-05       Impact factor: 4.965

6.  Late onset lupus: a clinical and immunological study in a predominantly Chinese population.

Authors:  E T Koh; M L Boey
Journal:  J Rheumatol       Date:  1994-08       Impact factor: 4.666

Review 7.  The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus.

Authors:  D Gladman; E Ginzler; C Goldsmith; P Fortin; M Liang; M Urowitz; P Bacon; S Bombardieri; J Hanly; E Hay; D Isenberg; J Jones; K Kalunian; P Maddison; O Nived; M Petri; M Richter; J Sanchez-Guerrero; M Snaith; G Sturfelt; D Symmons; A Zoma
Journal:  Arthritis Rheum       Date:  1996-03

8.  Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients.

Authors:  Ricard Cervera; Munther A Khamashta; Josep Font; Gian Domenico Sebastiani; Antonio Gil; Paz Lavilla; Juan Carlos Mejía; A Olcay Aydintug; Hanna Chwalinska-Sadowska; Enrique de Ramón; Antonio Fernández-Nebro; Mauro Galeazzi; Merete Valen; Alessandro Mathieu; Frédéric Houssiau; Natividad Caro; Paula Alba; Manuel Ramos-Casals; Miguel Ingelmo; Graham R V Hughes
Journal:  Medicine (Baltimore)       Date:  2003-09       Impact factor: 1.889

Review 9.  Cytokine production pathway in the elderly.

Authors:  C Caruso; G Candore; D Cigna; G DiLorenzo; G Sireci; F Dieli; A Salerno
Journal:  Immunol Res       Date:  1996       Impact factor: 2.829

10.  Prevalence of selected autoantibodies in different elderly subpopulations.

Authors:  A G Juby; P Davis; J E McElhaney; S Gravenstein
Journal:  Br J Rheumatol       Date:  1994-12
View more
  13 in total

1.  Late onset lupus nephritis: analysis of clinical manifestations and renal pathological features in Chinese patients.

Authors:  Zheng Tang; Dongmei Chen; Shengmei Yang; Haitao Zhang; Weixin Hu; Zhihong Liu; Leishi Li
Journal:  Rheumatol Int       Date:  2010-06-10       Impact factor: 2.631

Review 2.  Late-onset systemic lupus erythematosus: epidemiology, diagnosis and treatment.

Authors:  Laurent Arnaud; Alexis Mathian; Jacques Boddaert; Zahir Amoura
Journal:  Drugs Aging       Date:  2012-03-01       Impact factor: 3.923

3.  Age of onset influences on clinical and laboratory profile of patients with systemic lupus erythematosus.

Authors:  Rafael Hennemann Sassi; Jordana Vaz Hendler; Giovana Fagundes Piccoli; Andrese Aline Gasparin; Rafael Mendonça da Silva Chakr; João Carlos Tavares Brenol; Odirlei André Monticielo
Journal:  Clin Rheumatol       Date:  2016-11-17       Impact factor: 2.980

4.  A single mid-gestation exposure to TCDD yields a postnatal autoimmune signature, differing by sex, in early geriatric C57BL/6 mice.

Authors:  A Mustafa; S D Holladay; S Witonsky; D P Sponenberg; E Karpuzoglu; R M Gogal
Journal:  Toxicology       Date:  2011-09-06       Impact factor: 4.221

Review 5.  A case of very late-onset systemic lupus erythematosus and updated pooled analysis of late-onset cases in the literature.

Authors:  Fang Chen; Lu Zhang; Guochun Wang; Bing Lin; Liying Wang
Journal:  Rheumatol Int       Date:  2011-09-07       Impact factor: 2.631

6.  Prevalence, incidence, and demographics of systemic lupus erythematosus and lupus nephritis from 2000 to 2004 among children in the US Medicaid beneficiary population.

Authors:  Linda T Hiraki; Candace H Feldman; Jun Liu; Graciela S Alarcón; Michael A Fischer; Wolfgang C Winkelmayer; Karen H Costenbader
Journal:  Arthritis Rheum       Date:  2012-08

7.  Late-onset systemic lupus erythematosus: clinical features, course, and prognosis.

Authors:  Aleksandra Tomic-Lucic; Radmila Petrovic; Marija Radak-Perovic; Dragan Milovanovic; Jasmina Milovanovic; Sandra Zivanovic; Suzana Pantovic; Mirjana Veselinovic
Journal:  Clin Rheumatol       Date:  2013-03-21       Impact factor: 2.980

8.  Clinical expression and course in patients with late onset systemic lupus erythematosus.

Authors:  S Stefanidou; C Gerodimos; A Benos; V Galanopoulou; I Chatziyannis; F Kanakoudi; S Aslanidis; P Boura; T Sfetsios; L Settas; M Katsounaros; D Papadopoulou; P Giamalis; N Dombros; M Chatzistilianou; A Garyfallos
Journal:  Hippokratia       Date:  2013-04       Impact factor: 0.471

9.  Polymyalgia Rheumatica or Late Onset Lupus? A Case Report.

Authors:  Jake Altier; Jim Oates; Celine Ward
Journal:  J Investig Med High Impact Case Rep       Date:  2022 Jan-Dec

10.  Late-onset systemic lupus erythematosus: characteristics and outcome in comparison to juvenile- and adult-onset patients-a multicenter retrospective cohort.

Authors:  Basma M Medhat; Mervat Essam Behiry; Nesreen Sobhy; Yomna Farag; Huda Marzouk; Noha Mostafa; Iman Khalifa; Marwa Elkhalifa; Basma M Eissa; Eman Hassan ElSayed Hassan
Journal:  Clin Rheumatol       Date:  2019-11-22       Impact factor: 3.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.